This network highlighted the significance of four pathways, EGFR tyrosine kinase inhibitor resistance (hsa01521), the PI3K-Akt signaling pathway (hsa04151), MAPK signaling pathway (hsa04010), and apoptosis (hsa04210) in BC, in correlation with the highly ranked compounds, including hinokinin, 442879, hydroxylinolenic acid, 5312775, N-valeryl-valine, 36689743, peyssonoic acid B 46178008, and valeric acid, 7991 (Figure 6F). The gene discussed is AKT1; the disease is breast cancer.